De Silva Rajiv
Pres & COO, Specialty Pharm at BHC; Chief Operating Officer at VALEANT PHARMACEUTICALS INTERNATIONAL
- Sold, on record
- $23.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 8, 2012
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- BHCBausch Health Companies Inc.Pres & COO, Specialty Pharm
- VALEANT PHARMACEUTICALS INTERNATIONALChief Operating Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- BHC516,937 shares
- VALEANT PHARMACEUTICALS INTERNATIONAL23,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale VALEANT PHARMACEUTICALS INTERNATIONALPlan not statedJun 9, 2010 2010
Sold 23,000 shares at $45.24 ($1M)
De Silva Rajiv, Chief Operating Officer
Sold 19.2% of holdings ($5.4M position)96,488 shares leftFirst sale on recordFiling
- 2 Form 4 sale BHCUnusualDec 1, 2010 +175 days
Sold 219,897 shares at $27.00 ($5.9M)
De Silva Rajiv, President & COO Spec. Pharma.
Sold 43% of holdings ($13.8M position)291,794 shares leftFirst sale on recordFiling
- 3 Form 4 sale BHCUnusualNov 6, 2012 +706 days
Sold 220,696 shares at $54.38 ($12M)
De Silva Rajiv, Pres. & COO, Specialty Pharma
Sold 45.4% of holdings ($26.4M position)265,217 shares leftFiling
- 4 Form 4 sale BHCPlan not statedNov 8, 2012 +2 days
Sold 76,344 shares at $54.04 ($4.1M)
De Silva Rajiv, Pres & COO, Specialty Pharm
Sold 22.4% of holdings ($18.5M position)265,217 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2012 | Nov 9, 2012 | BHC | Pres & COO, Specialty Pharm | Form 4 sale | 76,344 | $4.1M | 22.4% | Plan not stated | SEC |
| Nov 6, 2012 | Nov 8, 2012 | BHC | Pres. & COO, Specialty Pharma | Form 4 sale | 220,696 | $12M | 45.4% | Unusual | SEC |
| Dec 1, 2010 | Dec 2, 2010 | BHC | President & COO Spec. Pharma. | Form 4 sale | 219,897 | $5.9M | 43.0% | Unusual | SEC |
| Jun 9, 2010 | Jun 11, 2010 | VALEANT PHARMACEUTICALS INTERNATIONAL | Chief Operating Officer | Form 4 sale | 23,000 | $1M | 19.2% | Plan not stated | SEC |